Heron Therapeutics Inc (NASDAQ: HRTX) is 46.41% higher on its value in year-to-date trading and has touched a low of $1.04 and a high of $3.93 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HRTX stock was last observed hovering at around $2.47 in the last trading session, with the day’s loss setting it -0.23%.
Currently trading at $2.24, the stock is 24.20% and 31.84% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.23 million and changing -9.31% at the moment leaves the stock 2.89% off its SMA200. HRTX registered -17.04% loss for a year compared to 6-month loss of 16.06%.
The stock witnessed a 29.48% gain in the last 1 month and extending the period to 3 months gives it a 103.64%, and is 26.55% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.56% over the week and 7.87% over the month.
Heron Therapeutics Inc (HRTX) has around 122 employees, a market worth around $341.21M and $144.28M in sales. Fwd P/E is 42.00. Profit margin for the company is -9.41%. Distance from 52-week low is 115.38% and -43.00% from its 52-week high. The company has generated returns on investments over the last 12 months (-9.63%).
with sales reaching $37.08M over the same period.The EPS is expected to grow by 50.00% this year, but quarterly earnings will post 9.62% year-over-year. Quarterly sales are estimated to grow 6.96% in year-over-year returns.
Heron Therapeutics Inc (HRTX) Top Institutional Holders
The shares outstanding are 152.13M, and float is at 150.77M with Short Float at 20.41%.
The top institutional shareholder in the company is RUBRIC CAPITAL MANAGEMENT LP with over 26.71 million shares valued at $93.5 million. The investor’s holdings represent 17.5395% of the HRTX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 8.62 million shares valued at $30.16 million to account for 5.6984 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 8.33 million shares representing 5.5062% and valued at over $29.14 million, while ADAGE CAPITAL PARTNERS GP, L.L.C. holds 4.99 of the shares totaling 7.6 million with a market value of $26.6 million.
Heron Therapeutics Inc (HRTX) Insider Activity
A total of 0 insider transactions have happened at Heron Therapeutics Inc (HRTX) in the last six months, with sales accounting for 0 and purchases happening 0 times.
Heron Therapeutics Inc (HRTX): Who are the competitors?
The company’s main competitors (and peers) include Ligand Pharmaceuticals Inc. (LGND) that is trading 47.06% up over the past 12 months. Pacira BioSciences Inc. (PCRX) that is -21.37% lower over the same period.
